Alnylam

Alnylam
Focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
RNA Interference
Gene Therapy
Drug Development
Biomedical Research
Alnylam在招职位
0个在招职位
目前没有在招职位
产品与服务
ON
ONPATTRO (patisiran)
Marketed Drug
RN
RNAi Platform Technology
Technology Platform
AM
AMVUTTRA (vutrisiran)
Marketed Drug
OX
OXLUMO (lumasiran)
Marketed Drug
GI
GIVLAARI (givosiran)
Marketed Drug

Drug Development Services
Services
CE
Cemdisiran
Pipeline Drug
LE
LEQVIO (inclisiran)
Partnered Drug
AL
ALN-APP
Pipeline Drug

Fitusiran
Pipeline Drug
AL
ALN-HBV02
Pipeline Drug
最新动态
All
X
News
HN
YouTube
Is the options market predicting a spike in Alnylam Pharmaceuticals stock? - MSN
MSN
News
·
1个月前
Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial - Yahoo Finance
Yahoo Finance
News
·
1个月前
Seagate, Alnylam among six companies set to join Nasdaq 100 - MSN
MSN
News
·
1个月前
Acrylamide
HN
·
1个月前
·
2
·
1
Bernstein SocGen cuts Alnylam stock price target on Amvuttra focus - Investing.com
Investing.com
News
·
1个月前
更多 (剩余15条)
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
评价
4.1
10条评价
工作生活平衡
2.8
薪酬
4.2
企业文化
4.0
职业发展
3.5
管理层
3.2
75%
推荐率
优点
Great benefits and health benefits
Collaborative team environment
Cutting-edge research and challenging projects
缺点
High workload and overwhelming demands
Work-life balance issues
Limited career advancement opportunities
薪资范围
69个数据点
Director
Intern
Mid/L4
Senior/L5
Director
1份报告
$231,400
年薪总额
基本工资
$178,000
股票
-
$231,400
$231,400
面试评价
3条评价
难度
3.0
/ 5
时长
2-5w
体验
正面 0%
中性 33%
负面 67%
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Round Interview
6
Offer
联系方式与地址